EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy

Triantafyllos Didangelos iD, Eleni Karlafti iD, Evangelia Kotzakioulafi iD, Parthena Giannoulaki iD, Zisis Kontoninas, Anastasia Kontana, Polykarpos Evripidou, Christos Savopoulos, Andreas L Birkenfeld, Konstantinos Kantartzis iD

Nutrients · 2024

DOI: 10.3390/nu16183045 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Triantafyllos Didangelos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Vitamin B 12, Thioctic Acid, Vitamin B 6. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pharma Unimedis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), nicotinamide (9 mg), and minerals (Mg 30 mg, Zn 2.5 mg) in one tablet in people with Diabetic Neuropathy (DN). Patients–methods: In the present pilot study, 73 people (age 63.0 ± 9.9 years, 37 women) with type 2 Diabetes Mellitus (DMT2) (duration 17.5 ± 7.3 years) and DN were randomly assigned to receive either the combination of ten elements (2 tablets/24 h) in the active group (n = 36) or the placebo (n = 37) for 6 months. We used the Michigan Neuropathy Screening Instrument Questionnaire and Examination (MNSIQ and MNSIE), measured vibration perception threshold (VPT) with biothesiometer, and Cardiovascular Autonomic Reflex Tests (CARTs). Nerve function was assessed by DPN Check [sural nerve conduction velocity (SNCV) and amplitude (SNAP)]. Sudomotor function was assessed with SUDOSCAN, which measures electrochemical skin conductance in hands and feet (ESCH and ESCF). Pain score (PS) was assessed with Pain DETECT questionnaire. Quality of life was assessed by questionnaire.

Results

In the active group, there was a large improvement of pain (PS from 20.9 to 13.9, p < 0.001). There was also a significant improvement of vitamin B12 (B12) levels, MNSIQ, SNCV, VPT, and ESCF (222.1 vs. 576.3 pg/ mL, p < 0.001; 6.1 vs. 5.9, p = 0.017; 28.8 vs. 30.4, p = 0.001; 32.1 vs. 26.7, p = 0.001; and 72.2 vs. 74.8, p < 0.001 respectively). In the placebo group, neither pain (21.6 vs. 21.7, p = 0.870) or any other aforementioned parameters changed significantly, and MNSIE worsened (2.9 vs. 3.4, p < 0.001). As a result, changes from baseline to follow-up in pain, B12 levels, VPT, and MNSIQ differed significantly between the two groups (p < 0.001, 0.025, 0.009, and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesVitamin B 12Thioctic AcidVitamin B 6Palmitic AcidsEthanolaminesSuperoxide DismutaseNiacinamideAmidesHumansMiddle AgedFemaleMaleAgedPilot ProjectsDiabetes Mellitus, Type 2ZincVitamin EDouble-Blind MethodThiamineTreatment OutcomeDietary Supplements

Stichwörter der Autor:innen

diabetes mellitus type 2diabetic neuropathyneuropathic painpainpainful diabetic neuropathysupplementsvitamin supplementation

Substanzen

Vitamin B 12palmidrolThioctic AcidVitamin B 6Palmitic AcidsEthanolaminesSuperoxide DismutaseNiacinamideAmidesZinc

Autor:innen und Institutionen

  • Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece.
  • Department of Clinical Nutrition and Dietetics, AHEPA Hospital, 54636 Thessaloniki, Greece.
  • Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University of Tübingen, 72076 Tübingen, Germany.
  • Institute for Diabetes Research and Metabolic Diseases (IDM), Helmholtz Centre Munich, University of Tübingen, 72076 Tübingen, Germany.
  • German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.

ORCID-Profile: Triantafyllos Didangelos, Eleni Karlafti, Evangelia Kotzakioulafi, Parthena Giannoulaki, Konstantinos Kantartzis

Förderung

  • Pharma Unimedis

Zitieren

APA

Didangelos, T., Karlafti, E., Kotzakioulafi, E., Giannoulaki, P., Kontoninas, Z., Kontana, A., Evripidou, P., Savopoulos, C., Birkenfeld, A. L., & Kantartzis, K. (2024). Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy. Nutrients. https://doi.org/10.3390/nu16183045

Vancouver

Didangelos T, Karlafti E, Kotzakioulafi E, Giannoulaki P, Kontoninas Z, Kontana A, et al. Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy. Nutrients. 2024. doi:10.3390/nu16183045

BibTeX
@article{Didangelos2024,
  author = {Didangelos, Triantafyllos and Karlafti, Eleni and Kotzakioulafi, Evangelia and Giannoulaki, Parthena and Kontoninas, Zisis and Kontana, Anastasia and Evripidou, Polykarpos and Savopoulos, Christos and Birkenfeld, Andreas L and Kantartzis, Konstantinos},
  title = {Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16183045}
}
Kostenlos starten →